Privacy Sandbox and Healthcare: Preparing for a Cookieless Future

For fifteen years, healthcare marketing teams relied on the same infrastructure as every other industry: third-party cookies. A visitor browsed a hospital's orthopedic surgery page, and a cookie followed them across the web, enabling retargeting ads, conversion measurement, and audience building. The system worked. It also created the conditions for $193 million in enforcement actions and settlements against healthcare organizations between 2023 and 2025.

Now that infrastructure is disappearing. Google's Privacy Sandbox initiative is replacing third-party cookies in Chrome with a set of browser-based APIs designed to preserve advertising functionality while limiting cross-site tracking. Safari and Firefox blocked third-party cookies years ago. Chrome, which holds roughly 65% of global browser market share, has been phasing in Privacy Sandbox APIs since 2023 and restricting third-party cookie access on an accelerating timeline.

For most industries, this is an advertising measurement problem. For healthcare, it is both a measurement problem and a compliance opportunity. The same tracking mechanisms that Privacy Sandbox is eliminating are the ones that generated the enforcement cases that have reshaped healthcare marketing compliance.

How Third-Party Cookies Created Healthcare's Tracking Problem

The mechanics are simple. A healthcare organization installs Meta Pixel or Google's advertising tags on its website. Those tags drop third-party cookies in the visitor's browser. When the visitor later appears on another website, the cookie identifies them, and the ad platform can attribute their behavior back to the healthcare site visit. If they convert (schedule an appointment, fill out a form), the loop closes.

The problem in healthcare is what that loop carries. When the original page visit was to a substance abuse treatment page, a fertility clinic's intake form, or a mental health provider's services page, the cookie links the visitor's identity to a health context. Every retargeting ad served based on that cookie implicitly reveals that the individual visited a healthcare page with specific health implications.

GoodRx's $25 million settlement illustrates this directly. GoodRx configured Meta Pixel and Google tracking pixels that shared prescription drug names, health conditions, and personal identifiers with Facebook, Google, and other ad platforms. The data was used for targeted advertising without consent. This was the first enforcement under the FTC Health Breach Notification Rule and set the precedent that health data flowing through advertising infrastructure triggers regulatory consequences. Source

Third-party cookies were the plumbing that made this data flow possible. Privacy Sandbox is designed to remove that plumbing. Understanding what replaces it matters for healthcare marketing teams planning their next two years of infrastructure.

What Privacy Sandbox Actually Introduces

Privacy Sandbox is not a single technology. It is a collection of APIs, each designed to replace a specific function that third-party cookies performed. The APIs most relevant to healthcare marketing are:

Topics API replaces interest-based targeting. Instead of tracking a user's browsing history via cookies, the browser itself classifies the user into broad interest categories (called "topics") based on their recent browsing. The browser shares a small subset of these topics with participating websites and ad tech platforms. Topics are intentionally coarse. Google's published taxonomy excludes sensitive categories, including health-related topics, from the API's output.

Attribution Reporting API replaces conversion measurement. Instead of a cookie linking an ad click to a later conversion event, the browser itself performs the attribution and sends an aggregated or delayed report to the advertiser. The reports are designed to prevent identifying individual users. They include noise (random data added for privacy) and enforce minimum aggregation thresholds before reporting results.

Protected Audience API (formerly FLEDGE) replaces remarketing and custom audiences. Instead of an ad server building audience lists from cross-site cookies, the browser stores audience membership locally. Ad auctions run on-device, and the ad platform never learns which specific audience group a user belongs to.

Shared Storage API provides limited cross-site storage for use cases like frequency capping and A/B testing, with strict access controls that prevent the stored data from being exfiltrated.

Each of these APIs moves computation from remote ad platform servers to the local browser. The design philosophy is that the browser acts as a trusted intermediary, giving advertisers aggregated signals without exposing individual user data.

Where Healthcare Marketing Gains and Loses

The shift away from third-party cookies changes the risk profile for healthcare marketing in both directions.

The compliance gain is significant. Third-party cookies were the primary mechanism through which healthcare organizations inadvertently shared PHI with advertising platforms. When cookies are eliminated, the most common vector for these data flows disappears. A hospital website that previously dropped Meta's third-party cookie alongside its own content can no longer leak that association through standard cookie-based retargeting.

The measurement loss is real but manageable. Healthcare organizations that relied on third-party cookie attribution to measure campaign performance will see those signals degrade. Google's Attribution Reporting API provides aggregate conversion data with intentional noise and delays. For organizations running large-scale campaigns, the aggregate data may be sufficient. For smaller healthcare systems with lower conversion volumes, the noise and aggregation thresholds could make individual campaign measurement difficult.

The Topics API exclusion matters. Google has stated that the Topics API taxonomy excludes sensitive categories, including health. This means healthcare-related browsing should not generate health topics that flow back to ad platforms. However, the exclusion is maintained by Google's taxonomy decisions, not by regulation. Healthcare organizations should not rely on a platform's voluntary taxonomy choices as a compliance control.

Remarketing changes fundamentally. Protected Audience API keeps audience membership on-device. A healthcare organization can theoretically add visitors to a "website visitor" audience for remarketing without that audience list existing on Meta or Google's servers. But the practical implementation requires careful evaluation. If the audience is defined by pages visited (e.g., "visitors to the oncology department page"), the audience definition itself carries health context, even if individual membership stays on-device.

Privacy Sandbox Does Not Solve HIPAA Compliance

It would be tempting to view Privacy Sandbox as a compliance solution. Third-party cookies go away, the primary leakage vector closes, and the problem is solved. This view is incorrect for several reasons.

First-party data collection remains unchanged. Privacy Sandbox addresses cross-site tracking. It does not affect what happens on your own website. Google Analytics, installed as a first-party script, still collects page URLs, user interactions, and behavioral data on your healthcare site and sends it to Google's servers. That data flow does not involve third-party cookies and is not affected by Privacy Sandbox. The December 2022 OCR guidance on tracking technologies applies to all tracking technologies, not just cookies.

Server-to-server data sharing is growing. As cookies disappear, platforms are pushing server-side APIs: Google's Enhanced Conversions, Meta's Conversions API (CAPI). These require healthcare organizations to send conversion data directly from their servers to ad platforms. If that data includes identifiers linked to health context, the HIPAA implications are the same as pixel-based sharing. The data path changed; the compliance question did not.

State health privacy laws apply regardless of cookies. Washington's My Health My Data Act, Connecticut's health data protections, and similar state laws regulate the collection and sharing of health data through any mechanism, not just cookies. Privacy Sandbox eliminates one technical mechanism but does not address the broader legal obligations that apply to health-related data.

Cerebral's $7 million FTC settlement demonstrates why the mechanism matters less than the data. Cerebral's tracking pixels sent patient names, prescription histories, and mental health questionnaire answers to Meta between 2019 and 2023. The violation was not about cookies specifically. It was about health data reaching an advertising platform without authorization. Whether that data travels via a cookie, a server-side API, or a Privacy Sandbox signal, the regulatory issue is the same. Source

Building for a Post-Cookie Healthcare Marketing Stack

The disappearance of third-party cookies is an opportunity to rebuild healthcare marketing infrastructure on a foundation that is both privacy-respecting and regulation-compliant. That foundation has several components.

Server-side architecture becomes the default. When third-party cookies disappear, client-side pixels lose much of their attribution capability anyway. This accelerates the shift to server-side data collection, where your servers control exactly what data reaches each vendor. In healthcare, server-side architecture is not just a performance choice. It is the architectural difference between "we control our data flows" and "the browser decides what to share."

First-party data strategy replaces cross-site tracking. Healthcare organizations that build consented, first-party relationships with patients (through patient portals, newsletters, appointment scheduling) can measure marketing effectiveness without relying on browser-based tracking of any kind. A server-side CDP can connect marketing touchpoints to outcomes using data that never leaves your infrastructure or your BAA-covered vendor stack.

Consent-gated data flows align with the direction of regulation. Privacy Sandbox is Google's response to consumer privacy expectations. State health privacy laws are legislatures' response. Both point in the same direction: data should only flow with informed consent. Healthcare organizations that implement consent-gated dispatch, where data only moves to downstream destinations after consent is verified server-side, are building for the regulatory environment that is emerging, not the one that is disappearing.

Continuous monitoring catches what transitions miss. As your organization migrates from cookie-based to Privacy Sandbox and server-side infrastructure, the transition period creates risk. Old tags may linger. New implementations may be misconfigured. A web scanner that continuously audits your site for cookies, scripts, and tracking pixels ensures nothing falls through the cracks during the transition.

FAQ

Will Privacy Sandbox make healthcare websites HIPAA compliant?

No. Privacy Sandbox addresses third-party cookie tracking but does not affect first-party data collection, server-side data sharing, or the fundamental question of whether health data reaches vendors without BAAs and proper authorization. Healthcare organizations still need compliant architecture for their entire marketing stack.

Does the Topics API share health-related browsing data?

Google's current Topics taxonomy excludes sensitive categories, including health. However, this exclusion is a platform policy decision, not a technical guarantee or regulatory requirement. Healthcare organizations should not rely on it as a compliance control and should implement their own safeguards through server-side architecture.

How should healthcare marketers measure campaign performance without third-party cookies?

Server-side conversion tracking, first-party data matching through compliant infrastructure, and Google's Attribution Reporting API (for aggregate measurement) are the primary alternatives. A server-side CDP can connect marketing touchpoints to patient actions without exposing health data to ad platforms. The key is ensuring that any data shared with advertising platforms passes through infrastructure covered by a BAA.

Do I still need to worry about tracking pixels if cookies are going away?

Yes. Tracking pixels (like Meta Pixel) are shifting to cookieless mechanisms, including first-party cookies, browser fingerprinting, and server-side APIs. The pixel itself is not going away; its underlying tracking technology is changing. A pixel on a healthcare website still sends data to Meta's servers, regardless of whether a third-party cookie is involved.

What should healthcare organizations do right now to prepare?

Audit your current tracking infrastructure for third-party cookie dependencies. Evaluate whether your server-side alternatives have proper BAA coverage. Implement consent-gated data flows that meet both HIPAA and state privacy law requirements. Begin migrating campaign measurement to first-party, server-side architecture. The transition away from cookies is already underway; organizations that wait for full deprecation will be scrambling.

The end of third-party cookies removes one compliance risk vector but does not eliminate the fundamental challenge of healthcare marketing compliance: ensuring that health data only flows to authorized, BAA-covered destinations with proper consent. If your organization is planning its post-cookie marketing infrastructure, Ours Privacy provides the server-side architecture and consent management designed to meet both current HIPAA requirements and emerging state privacy laws.

Related reading:

• What Is Server-Side Tracking? A Guide for Healthcare Marketers

• First-Party vs Third-Party Data in Healthcare Marketing

• Client-Side vs Server-Side Analytics: The Healthcare Decision

• What Is Conversion API (CAPI)? Healthcare Implementation Explained